All items are mission critical: reagents required to pre screen blood products for donation. Failure to acquire, would result in total work stoppage.
Ended Awarded
- Contract number
- HT009025FG0730034
- Awardee
-
Abbott Laboratories Inc. UEI NH3LDK8CFAK7 Part of Abbott Laboratories Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $171,574
Award facts
- Contract value 100% obligated
- $171,574.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 7 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Chicago, IL 60064, USA
Award details come from SAM.gov/FPDS.
About this award
Abbott Laboratories Inc., through its Abbott Diagnostics Division, received a $171,574 firm fixed-price Blanket Purchase Agreement (BPA) call award from the Defense Health Agency on July 19, 2025, with performance completion targeted for September 30, 2025. The contract involves mission-critical reagents required to pre-screen blood products for donation, with the contracting officer noting that failure to acquire these items would result in total work stoppage. Performance will be conducted at Abbott's facility in North Chicago, Illinois. This award represents a child contract under Abbott's broader portfolio of diagnostic and laboratory services provided to federal healthcare organizations.
This BPA call was issued without set-aside designation, indicating full and open competition. The award reflects Abbott Laboratories' established role as a critical supplier of advanced medical diagnostic technologies and clinical laboratory solutions to the Defense Health Agency and other federal healthcare systems. Abbott's extensive contract portfolio with the Department of Veterans Affairs, Defense Health Agency, and Indian Health Service demonstrates the company's strategic positioning in federal healthcare procurement, particularly for sophisticated medical testing technologies, immunochemistry analyzers, reagents, and associated consumables that support essential clinical operations across government healthcare facilities.
Quick answers
Who was awarded contract HT009025FG0730034?
HT009025FG0730034 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on July 19, 2025.
How much is contract HT009025FG0730034 worth?
The government has obligated $171,574 on HT009025FG0730034.
Is contract HT009025FG0730034 an order under another contract?
Yes. HT009025FG0730034 is a BPA call under FA301624A0044, a blanket purchase agreement.
Was contract HT009025FG0730034 competed?
The extent of competition for HT009025FG0730034 was competed under sap. The government received 7 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award